60 Degrees Pharmaceuticals (SXTPW) Competitors

$0.04

0.00 (0.00%)

(As of 09/18/2024 ET)

SXTPW vs. ATNFW, DRTSW, WENAW, APLMW, BCAX, BCTXW, CDIOW, CTCXW, CELUW, and CEROW

Should you be buying 60 Degrees Pharmaceuticals stock or one of its competitors? The main competitors of 60 Degrees Pharmaceuticals include 180 Life Sciences (ATNFW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), Bicara Therapeutics (BCAX), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry.

60 Degrees Pharmaceuticals vs.

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, community ranking, earnings, dividends, media sentiment, risk and analyst recommendations.

: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
60 Degrees Pharmaceuticals $418.30K N/A N/A N/A N/A
180 Life Sciences N/A N/A N/A N/A N/A
: In the previous week, 180 Life Sciences had 1 more articles in the media than 60 Degrees Pharmaceuticals. MarketBeat recorded 2 mentions for 180 Life Sciences and 1 mentions for 60 Degrees Pharmaceuticals. 60 Degrees Pharmaceuticals' average media sentiment score of 1.89 beat 180 Life Sciences' score of 1.44 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the media.
Company Overall Sentiment
60 Degrees Pharmaceuticals Very Positive
180 Life Sciences Positive
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
60 Degrees Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
180 Life Sciences
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
: Company Net Margins Return on Equity Return on Assets
60 Degrees Pharmaceuticals N/A N/A N/A
180 Life Sciences N/A N/A N/A
: 60 Degrees Pharmaceuticals and 180 Life Sciences both received 0 outperform votes by MarketBeat users.
Company Underperform Outperform
60 Degrees Pharmaceuticals N/A N/A
180 Life Sciences N/A N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
60 Degrees Pharmaceuticals	$418.30K	N/A	N/A	N/A	N/A
180 Life Sciences	N/A	N/A	N/A	N/A	N/A

Company	Overall Sentiment
60 Degrees Pharmaceuticals	Very Positive
180 Life Sciences	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
60 Degrees Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
180 Life Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Company	Net Margins	Return on Equity	Return on Assets
60 Degrees Pharmaceuticals	N/A	N/A	N/A
180 Life Sciences	N/A	N/A	N/A

Company	Underperform	Outperform
60 Degrees Pharmaceuticals	N/A	N/A
180 Life Sciences	N/A	N/A

Summary

60 Degrees Pharmaceuticals beats 180 Life Sciences on 2 of the 3 factors compared between the two stocks.

Ad Paradigm Press

[Urgent] Starlink Set For The Largest IPO In History?

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.

Click here now for the urgent details on this hidden play.

Get 60 Degrees Pharmaceuticals News Delivered to You Automatically

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SXTPW vs. The Competition

Export to Excel

Metric	60 Degrees Pharmaceuticals	Biotechnology Industry	Medical Sector	NASDAQ Exchange
Market Cap	N/A	$207.38M	$5.64B	$8.25B
Dividend Yield	N/A	3.44%	4.33%	4.08%
P/E Ratio	N/A	318.12	145.21	18.57
Price / Sales	N/A	12,064.90	1,614.70	73.26
Price / Cash	N/A	12.06	36.85	31.87
Price / Book	N/A	6.78	4.83	4.54
Net Income	N/A	-$25.03M	$114.76M	$224.04M
7 Day Performance	N/A	-0.79%	4.28%	5.48%
1 Month Performance	N/A	3.89%	9.53%	8.73%
1 Year Performance	N/A	11.60%	29.01%	12.32%

60 Degrees Pharmaceuticals Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	Employee Count	Indicator(s)
ATNFW 180 Life Sciences	0 of 5 stars 0.00 / 5 stars	$0.01 flat	N/A	-45.1%	$0.00	N/A	7	Positive News Gap Up
DRTSW Alpha Tau Medical	0 of 5 stars 0.00 / 5 stars	$0.18 flat	N/A	-35.6%	$0.00	N/A	80	News Coverage Positive News Gap Down
WENAW Anew Medical	0 of 5 stars 0.00 / 5 stars	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	Gap Down
APLMW Apollomics	0 of 5 stars 0.00 / 5 stars	$0.01 flat	N/A	-86.5%	$0.00	N/A	59
BCAX Bicara Therapeutics	0 of 5 stars 0.00 / 5 stars	N/A	N/A	N/A	$0.00	N/A	32	Insider Buying News Coverage High Trading Volume
BCTXW BriaCell Therapeutics	0 of 5 stars 0.00 / 5 stars	$0.19 +5.6%	N/A	-92.4%	$0.00	N/A	8	Gap Down
CDIOW Cardio Diagnostics	0 of 5 stars 0.00 / 5 stars	$0.03 flat	N/A	-33.5%	$0.00	$39,138.00	7	Positive News Gap Down
CTCXW Carmell	0 of 5 stars 0.00 / 5 stars	$0.06 -14.3%	N/A	N/A	$0.00	$12,320.00	9	Positive News
CELUW Celularity	0 of 5 stars 0.00 / 5 stars	$0.02 flat	N/A	-44.4%	$0.00	$22.77M	220	Positive News Gap Down
CEROW CERo Therapeutics	0 of 5 stars 0.00 / 5 stars	$0.01 flat	N/A	N/A	$0.00	N/A	8	Gap Down